Bioline Rx reported $21.58M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Arca Biopharma USD 884.56M 489.31M Jun/2026
Bio Path USD 677K 14K Mar/2026
Bioline Rx USD 21.58M 2.1M Mar/2026
Capricor Therapeutics USD 242.13M 40.96M Jun/2026